GeneThera, Inc.
GTHR · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $534 | $741 | $1,295 | $1,097 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $814 | $807 | $815 | $811 |
| Enterprise Value | $1,347 | $1,547 | $2,110 | $1,909 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$124 | -$147 | -$131 | -$271 |
| % Margin | – | – | – | – |
| Net Income | -$126 | -$148 | -$133 | -$275 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.004 | -0.004 | -0.01 |
| % Growth | 14% | -10.3% | 60.6% | – |
| Operating Cash Flow | $6 | -$5 | -$4 | -$10 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $6 | -$5 | -$4 | -$10 |